Rhumatologic disorders of Sarcoïdosis;Les manifestations rhumatologiques de la Sarcoidose

Tunisie Medicale

Volumn 88, Issue 11, 2010, Pages 773-782

  Hamdi, Wafa ^a   Néji, Olfa ^a   Ghannouchi, Mohamed Mehdi ^a   Kaffel, Dhia ^a   Kchir, Mohamed Montacer ^a  

^a Institut National Mohammed Kassab d'Orthopedie   (Tunisia)

Author keywords

Dactylitis; Hypercalcemia; Myositis; Osteolysis; Polyarthritis; Sarco dosis

Indexed keywords

CD20 ANTIBODY; CORTICOSTEROID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ARTICLE; HUMAN; HYPERCALCEMIA; OSTEOLYSIS; POLYARTHRITIS; RHEUMATIC DISEASE; SARCOIDOSIS; SARCOIDOSIS DACTYLITIS;

BONE DISEASES; HUMANS; SARCOIDOSIS;

EID: 78149344607     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Valeyre D, Nunes H, Duperron F, Soler P, Kambouchner M, Brauner M. Sarcoïdose. EMC-Pneumologie 2005;2:147-64.
2. Chaouat Y, Benichou C. La maladie de Perthes-Jungling. Gaz Med Fr 1964;71:1125-30.
3. Lofgren S. Age distribution of erythema nodosum. Acta Med Scand. 1950;136:241-9.
4. Handa T, Nagai S, Ito I et al. Multiple bone fractures found in a young sarcoidosis patient with long stable disease. Intern Med 2005;44:1269-75.
5. Imai S, Matsusue Y. Recurrent solitary sarcoidosis in bone - a case report. Acta Orthop Scand 2003;74:626-8.
6. Neville E, Carstairs S, Geraint James D. Sarcoidosis of bone. Q J Med 1977;46:215-27.
7. Alaoui FZ, Talaoui M, Benamour S. Manifestations ostéoarticulaires de la sarcoïdose. Presse Med 2005;34:19-24.
8. Karkowski L, Carassou P, Debourdeau P, Crevon L, Pavic M. Une ostéolyse des doigts. Rev Med Interne 2008;29:63-4..
9. Sartoris DJ, Resnick D, Resnick C, Yaghmai I. Musculoskeletal manifestations of sarcoidosis. Semin Roentgenol 1985;20:376-86.
10. Mathur A, Kremer JM. Immunopathology, rheumatic features and therapy of sarcoidosis. Curr Opin Rheumatol 1992;4:76-80.
11. Allanore Y, Perrot S, Menkès CJ, Kahan A. Traitement d'une atteinte osseuse sarcoïdosique bifocale associant calcanéite et dactylite. Rev Rhum 2001;68:273-6.
12. Santiago MB, Lima I, Feitosa AC, Braz Ade S, Miranda LG. Pseudoclubbing is it different from clubbing? Semin Arthritis Rheum 2009;38:452-7.
13. Torralba KD, Quismorio FP Jr. Sarcoidosis arthritis: a review of clinical features, pathology and therapy. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:95-103.
14. Schwartzbauer HR, Tami TA. Ear, nose, and throat manifestations of sarcoidosis. Otolaryngol Clin North Am. 2003; 36: 673-84.
15. Bouvier M, Lejeune E, Queneau P, Ryon M. Sarcoïdose avec lacunes crâniennes. Rev Rhum 1972;39:205-14.
16. Thuong M, Louvet Ch, Bondeville JM et al. Atteinte osseuse du calcanéum au cours de la sarcoïdose. A propos d'un cas. Rev Med Interne 1992;13:378-80.
17. Goobar IE, Gilmer WS, Caroll S et al. Vertebral sarcoidosis. JAMA 1961;178:1162-3.
18. Zener JC, Alpert M, Klainer LM. Vertebral sarcoidosis. Arch Intern Med 1963;111:696-712.
19. Clarençon F, Silbermann-Hoffman O, Lebreton C et al. Diffuse spine involvement in sarcoidosis with sternal lytic lesions: two case reports. Spine 2007;32:E594-7.
20. Mangino D, Stover DE. Sarcoidosis Presenting as Metastatic Bony Disease. A Case Report and Review of the Literature on Vertebral Body Sarcoidosis. Respiration 2004;71:292-4.
21. Nijjar SS, Leslie WD. A case of skeletal sarcoidosis imitating skeletal metastases on bone scintigraphy. CMAJ (Canadian Medical Association Journal ) 2008;178:153-4.
22. Koïke H, Misu K, Yasui K and al. Differential response to corticosteroid therapy of MRI findings and clinical manifestations in spinal cord sarcoidosis. J Neurol 2000;247:544-9.
23. Clifton AG, Stevens JM, Kapoor R, Rudge P. Spinal cord sarcoidosis with intramedullary cyst formation. Br J Radiol 1990;63:805-8.
24. Misawa M, Utsumi K, Nagate A et al. A case of spinal sarcoidosis complaining of chest and back pain as a first manifestation and mimicking syringomyelia on MRI. No To Shinkei 2002;54:337-40.
25. Kheiralla IC, Cherfan J, Schlienger IL, Imler M. Localisation sternale d'une sarcoïdose. Rev Med Interne 1990;11:229-30.
26. Vanek J, Vielpeau C, Brun J, Mandard JC. An unusual cause of fracture of the femoral neck: bone sarcoidosis. Rev Chir Orthop Reparatrice Appar Mot 1993;79:317-9.
27. Rozenberg C, Laredo JD, Rozenberg S, Starre JP, Bourgeois P. Bilateral Diaphysial tibial hyperostosis: a confusing hyperostosis. Joint bone Spine 2008;75:751-2.
28. Healy DJ, Helliwell PS. Dactylitis: pathogenesis and clinical considerations. Curr Rheumatol Rep 2006;8:338-41.
29. Heijckmann AC, Huijberts MS, De Vries J et al. Bone turnover and hip bone mineral density in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2007;24:51-8.
30. Heijckmann AC, Drent M, Dumitrescu B et al. Progressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study. Osteoporos Int 2008;19:839-47.
31. Mañá J, Gómez-Vaquero C, Montero A et al. Löfgren's syndrome revisited: a study of 186 patients. Am J Med 1999;107:240-5.
32. Mrazek F, Holla LI, Hutyrova B et al. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005;65:163-71.
33. Van Aken J, van Bilsen JH, Allaart CF, Huizinga TW, Breedveld FC. The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 2003;21:S100-5.
34. Mañá J, Gómez-Vaquero C, Salazar A, Valverde J, Juanola X, Pujol R. Periarticular ankle sarcoidosis: a variant of Löfgren's syndrome. J Rheumatol 1996;23:874-7.
35. Matsuda M, Sakurai K, Fushimi T et al. Sarcoidosis with high serum levels of vascular endothelial growth factor (VEGF), showing RS3PE-like symptoms in extremities. Clin Rheumatol 2004;23:246-8.
36. Kellner H, Späthling S, Herzer P. Ultrasound findings in Löfgren's syndrome: is ankle swelling caused by arthritis, tenosynovitis or periarthritis? J Rheumatol 1992;19:38-41.
37. Ortiz V, Holgado S, Olivé A, Fité E. Achilles tendinitis as the presentation form of Löfgren's syndrome. Clin Rheumatol 2000;19:169-70.
38. Sukenik S, Hendler N, Yerushalmi B, Buskila D, Liberman N. Jaccoud's-type arthropathy: an association with sarcoidosis. J Rheumatol 1991;18:915-7.
39. Niemer GW, Bolster MB, Buxbaum L, Judson MA. Carpal tunnel syndrome in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:296-300.
40. Fayad F, Duet M, Orcel P, Lioté F. Sarcoïdose systémique: le signe de "l'homme léopard". Rev Rhum 2006;73:109-13.
41. Enzenauer RJ, West SG. Sarcoidosis in autoimmune disease. Semin Arthritis Rheum 1992;22:1-17.
42. Moore SL, Teirstein AE. Musculoskeletal Sarcoidosis: Spectrum of Appearances at MR Imaging. Radiographics 2003;23:1389-99.
43. Yamada H, Ishii W, Ito S et al. Sarcoid myositis with muscle weakness as a presenting symptom. Mod Rheumatol 2007;17:243-6.
44. Fayad F, Lioté F, Berenbaum F, Orcel P, Bardin T. Muscle involvement in sarcoidosis: a retrospective and followup studies. J Rheumatol 2006;33:98-103.
45. Zámecník J, Ambler Z, Ehler E, Simková L, Mazanec R, Schützner J. Granulomatous myopathy in patients with sarcoidosis and myasthenia gravis. Cesk Patol 2006;42:175-81.
46. Nagai Y, Hisada T, Ando M, Ishikawa O. Fatal polymyositis associated with sarcoidosis. Eur J Dermatol 2007;17:453-4.
47. Gdynia HJ, Mogel H, Kühnlein P et al. Diagnosis and differential diagnosis of granulomatous myositis. Nervenarzt 2008;79:470-4.
48. Le Roux K, Streichenberger N, Vial C et al. Granulomatous myositis: a clinical study of thirteen cases. Muscle Nerve 2007;35:171-7.
49. Gardner DG. Hypercalcemia and sarcoidosis. Another piece of the puzzle falls into place. Am J Med 2001;110:736-7.
50. Adams JS, Gacad MA, Diz MM, Nadler JL. A role for endogenous arachidonate metabolites in the regulated expression of the 25-hydroxyvitamin D-1-hydroxylation reaction in cultured alveolar macrophages from patients with sarcoidosis. J Clin Endocrinol Metab 1990;70:595-600.
51. Falk S, Kratzsch J, Paschke R, Koch CA. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D. Med Sci Monit 2007;13:133-6.
52. Bia MJ, Insogna K. Treatment of sarcoidosis-associated hypercalcemia with ketoconazole. Am J Kidney Dis 1991;18:702-5.
53. Franco M, Passeron C, Tieulie N, Verdier JF, Benisvy D. Long-term radiographic follow-up in a patient with osteosclerotic sarcoidosis of the spine and pelvis. Rev Rhum Engl Ed 1998;65:586-90.
54. Erb N, Cushley MJ, Kassimos DG, Shave RM, Kit GD. An assessment of back pain and the prevalence of sacroiliitis in sarcoidosis. Chest 2005;127:192-6.
55. Ramos-Casals M, Brito-Zeron P, Garcia-Carrasco, Font J. Sarcoidosis or Sjogren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore) 2004;83:85-95.
56. Andonopoulos AP, Papadimitriou C, Melachrinou M et al. Asymptomatic gastrocnemius muscle biopsy: an extremely sensitive and specific test in the pathologic confirmation of sarcoidosis presenting with hilar adenopathy. Clin Exp Rheumatol 2001;19:569-72.
57. Menkes C.J., Carter H. Traitement de la dactylite sarcoïdosique par perfusion intraveineuse brève de méthylprednisolone à forte dose. Ann Med Interne 1987;138:26-9.
58. Kaye O, Palazzo E, Grossin M, Bourgeois P, Kahn MF, Malaise MG. Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol 1995;34:642-4.
59. Gardner GC, Hunter JC. Radiographic healing of osseous sarcoidosis. Arthritis Rheum 2005;52:2225.
60. Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:70-4.
61. Baughman RP, Iannuzzi M. Tumour Necrosis Factor in sarcoidosis and its potential for targeted therapy. Biodrugs 2003;17:425-31.
62. Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE. Successful tumor necrosis factor • blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 2003;48:3542-3.
63. Pritchard C, Nadarajah K. Tumour necrosis factor • inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients. Ann Rheum Dis 2004;63:318-20.
64. Sweiss NJ, Welsch MJ, Curran JJ, Ellman MH. Tumor Necrosis Factor inhibition as a novel treatment for refractory sarcoidosis. Arthritis Rheum 2005;53:788-91.
65. Siame JL, Le Dantec L, Gheerbrant JD. Sarcoïdose réfractaire, effets spectaculaires des anti-TNF: un cas. Rev Rhum 2006;73:1245.
66. Khanna D, Liebling MR, Louie JS. Etanercept ameliorates sarcoidosis arthritis and skin disease. J Rheumatol 2003;30:1864-7.
67. Hobbs K. Chronic sarcoid arthritis treated with intraarticular etanercept. Arthritis Rheum 2005;52:987-8.
68. Baughman RP, Lower EE, Bradley DA, Raymond LA, Kaufman A. Etanercept for Refractory Ocular Sarcoidosis. Results of a Double-Blind Randomized Trial. Chest 2005;128:1062-47.
69. Aelion JA, Odhav SK, Aelion M. Chronic recalcitrant sarcoidosis responding to adalimumab. Arthritis Rheum 2004;50(Suppl):S137-S138.
70. O'Shea FD et al. Pulmonary sarcoidosis developing during infliximab therapy. Arthritis Care Res 2006;55:978-81.
71. Gonzalez-Lopez MA et al. Development of sarcoidosis during etanercept therapy. Arthritis Care Res 2006;55:817-20.
72. Houvenagel E, Luraschi H, Maury F, Mulliez P. Sarcoïdose apparaissant sous etanercept chez une patiente suivie pour polyarthrite rhumatoïde. Rev Rhum 2007;74:1180.
73. Gottenberg J, Guillevin L, Lambotte O et al. Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 2005;64:913-20.
74. Belkhou A, Younsi R, El Bouchti I, El Hassani S. Rituximab comme alternative thérapeutique dans la sarcoïdose. Rev Rhum 2008;75:698-9.